Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001543405 | SCV004513351 | uncertain significance | ALG3-congenital disorder of glycosylation | 2023-02-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALG3 protein function. ClinVar contains an entry for this variant (Variation ID: 1184847). This missense change has been observed in individual(s) with congenital disorder of glycosylation type 1 (PMID: 33583022). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 250 of the ALG3 protein (p.Leu250Gln). |
University of Washington Center for Mendelian Genomics, |
RCV001543405 | SCV001761963 | pathogenic | ALG3-congenital disorder of glycosylation | no assertion criteria provided | research |